Targeting the ubiquitin proteasome system: beyond proteasome inhibition.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Current pharmaceutical design

• Publication date

  2013-06-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1381612811319220014PMID 23181575
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Benzimidazole-2-one: a novel anchoring principle for antagonizing p53-Mdm2.

  2013cited by this paper
• Identification and application of NEDD8 E1 inhibitors.

  2012cited by this paper
• A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma.

  2012cited by this paper
• The deubiquitinating enzyme USP36 controls selective autophagy activation by ubiquitinated proteins

  2012cited by this paper
• The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer

  2012cited by this paper
• Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme.

  2012cited by this paper
• BAP1 is a good prognostic factor in advanced non-small cell lung cancer.

  2012cited by this paper
• Genome-Wide Association Analysis of Meat Quality Traits in a Porcine Large White × Minzhu Intercross Population

  2012cited by this paper
• An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma.

  2012cited by this paper
• GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1α.

  2012cited by this paper
• Ubiquitin-like proteins.

  2012cited by this paper
• Molecular Basis of Lys-63-linked Polyubiquitination Inhibition by the Interaction between Human Deubiquitinating Enzyme OTUB1 and Ubiquitin-conjugating Enzyme UBC13*

  2012cited by this paper
• The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth.

  2012cited by this paper
• Copy Number Variations on Chromosome 4q26–27 Are Associated with Cantu Syndrome

  2012cited by this paper
• Evaluation of MLN4924, an investigational NEDD8-activating enzyme (NAE) inhibitor, as a novel targeted agent with single-agent antitumor activity in mantle cell lymphoma (MCL) and Hodgkin lymphoma preclinical models.

  2012cited by this paper
• SUMO playing tag with ubiquitin.

  2012cited by this paper
• A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.

  2012cited by this paper
• Strategies to Identify Recognition Signals and Targets of SUMOylation

  2012cited by this paper
• Systematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosome- and microtubule-associated functions

  2012cited by this paper
• The Deubiquitylase USP37 Links REST to the Control of p27 Stability and Cell Proliferation

  2012cited by this paper
• Initial testing of the investigational NEDD8‐activating enzyme inhibitor MLN4924 by the pediatric preclinical testing program

  2012cited by this paper
• RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation.

  2012cited by this paper
• Phosphorylation-dependent activity of the deubiquitinase DUBA

  2012cited by this paper
• USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma

  2012cited by this paper
• The small molecule inhibitor PR-619 of deubiquitinating enzymes affects the microtubule network and causes protein aggregate formation in neural cells: implications for neurodegenerative diseases.

  2012cited by this paper
• Regulation of NF-κB signaling by the A20 deubiquitinase

  2012cited by this paper
• Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes

  2012cited by this paper
• Roles of p97-associated deubiquitinases in protein quality control at the endoplasmic reticulum.

  2012cited by this paper
• Profiling Ubiquitin Linkage Specificities of Deubiquitinating Enzymes with Branched Ubiquitin Isopeptide Probes

  2012cited by this paper
• Identification Of Small Molecule TRABID Deubiquitinase Inhibitors By Computation-Based Virtual Screen

  2012cited by this paper
• Ubiquitin-Specific Protease 25 Functions in Endoplasmic Reticulum-Associated Degradation

  2012cited by this paper
• Regulation of NF‐κB by deubiquitinases

  2012cited by this paper
• Identification and Mechanistic Studies of a Novel Ubiquitin E1 Inhibitor

  2012cited by this paper
• The co-crystal structure of ubiquitin carboxy-terminal hydrolase L1 (UCHL1) with a tripeptide fluoromethyl ketone (Z-VAE(OMe)-FMK).

  2012cited by this paper
• Atypical ubiquitylation — the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages

  2012cited by this paper
• Glycine Fluoromethylketones as SENP‐Specific Activity Based Probes

  2012cited by this paper
• miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.

  2012cited by this paper
• Deubiquitinases in cancer: new functions and therapeutic options

  2012cited by this paper
• Ubiquitination in signaling to and activation of IKK

  2012cited by this paper
• Suppression of Jab1/CSN5 induces radiation- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways

  2012cited by this paper
• Role of CSN5/JAB1 in Wnt/β‐catenin activation in colorectal cancer cells

  2012cited by this paper
• Inauhzin and Nutlin3 synergistically activate p53 and suppress tumor growth

  2012cited by this paper
• The 26S proteasome complex: an attractive target for cancer therapy.

  2012cited by this paper
• Isolation of NEDDylated proteins in human cells.

  2012cited by this paper
• Probing the specificity and activity profiles of the proteasome inhibitors bortezomib and delanzomib.

  2012cited by this paper
• The proteasomal de‐ubiquitinating enzyme POH1 promotes the double‐strand DNA break response

  2012cited by this paper
• The ubiquitin E1 enzyme Ube1 mediates NEDD8 activation under diverse stress conditions

  2012cited by this paper
• Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation

  2012cited by this paper
• The 19S cap puzzle: a new jigsaw piece.

  2012cited by this paper
• Treatment-emergent mutations in NAEβ confer resistance to the NEDD8-activating enzyme inhibitor MLN4924.

  2012cited by this paper
• Expression and Clinical Significance of UCH37 in Human Esophageal Squamous Cell Carcinoma

  2012cited by this paper
• p53–Mdm2 inhibitors: patent review (2009 – 2010)

  2012cited by this paper
• NEDD8 overexpression results in neddylation of ubiquitin substrates by the ubiquitin pathway.

  2012cited by this paper
• VCIP135 deubiquitinase and its binding protein, WAC, in p97ATPase‐mediated membrane fusion

  2011cited by this paper
• Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response

  2011cited by this paper
• The p53-MDM2/MDMX axis - A chemotype perspective.

  2011cited by this paper
• Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes.

  2011influential reference
• Selective and cell-active inhibitors of the USP1/ UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells.

  2011cited by this paper
• PR‐924, a selective inhibitor of the immunoproteasome subunit LMP‐7, blocks multiple myeloma cell growth both in vitro and in vivo

  2011cited by this paper
• Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer

  2011cited by this paper
• Localization of ubiquitin specific protease 26 at blood-testis barrier and near Sertoli cell-germ cell interface in mouse testes.

  2011cited by this paper
• Protein stability of mitochondrial superoxide dismutase SOD2 is regulated by USP36

  2011cited by this paper
• Treatment-Induced Oxidative Stress and Cellular Antioxidant Capacity Determine Response to Bortezomib in Mantle Cell Lymphoma

  2011cited by this paper
• Overexpression of Ubiquitin Specific Protease 44 (USP44) Induces Chromosomal Instability and Is Frequently Observed in Human T-Cell Leukemia

  2011cited by this paper
• Nuclear organization in genome stability: SUMO connections

  2011cited by this paper
• Oncogenomics to Target Myeloma in the Bone Marrow Microenvironment

  2011influential reference
• USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation

  2011cited by this paper
• Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer

  2011cited by this paper
• Ubiquitin-Specific Peptidase 20 Targets TRAF6 and Human T Cell Leukemia Virus Type 1 Tax To Negatively Regulate NF-κB Signaling

  2011cited by this paper
• An Atlas of Altered Expression of Deubiquitinating Enzymes in Human Cancer

  2011cited by this paper
• Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression

  2011cited by this paper
• Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3

  2011cited by this paper
• Changes in the ratio of free NEDD8 to ubiquitin triggers NEDDylation by ubiquitin enzymes

  2011cited by this paper
• Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression.

  2011cited by this paper
• Global identification of modular cullin-RING ligase substrates.

  2011cited by this paper
• Development of small molecule inhibitors and probes of human SUMO deconjugating proteases.

  2011cited by this paper
• Carfilzomib-Dependent Selective Inhibition of the Chymotrypsin-like Activity of the Proteasome Leads to Antitumor Activity in Waldenstrom's Macroglobulinemia

  2011cited by this paper
• TSPYL5 suppresses p53 levels and function by physical interaction with USP7

  2011cited by this paper
• Bortezomib-induced peripheral neuropathy: facts and genes.

  2011cited by this paper
• Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2.

  2011cited by this paper
• Characterization of MRFAP1 Turnover and Interactions Downstream of the NEDD8 Pathway

  2011cited by this paper
• Autophagy as a target for anticancer therapy

  2011cited by this paper
• Specific and prolonged proteasome inhibition dictates apoptosis induction by marizomib and its analogs.

  2011cited by this paper
• The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78.

  2011influential reference
• The De-Ubiquitinylating Enzyme, USP2, Is Associated with the Circadian Clockwork and Regulates Its Sensitivity to Light

  2011cited by this paper
• Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.

  2011cited by this paper
• Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation.

  2011cited by this paper
• Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era.

  2011cited by this paper
• Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry.

  2011cited by this paper
• Atypical Mechanism of NF-κB activation by TRE17/Ubiquitin-Specific Protease 6 (USP6) oncogene and its requirement in tumorigenesis

  2011cited by this paper
• Proteasome structure, function, and lessons learned from beta-lactone inhibitors.

  2011influential reference
• USP47 is a deubiquitylating enzyme that regulates base excision repair by controlling steady-state levels of DNA polymerase β.

  2011cited by this paper
• Uncovering Ubiquitin and Ubiquitin-like Signaling Networks

  2011cited by this paper
• HPV E6 proteins target Ubc9, the SUMO conjugating enzyme.

  2011cited by this paper
• Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1

  2011cited by this paper
• Molecular Pathways: Targeting Proteasomal Protein Degradation in Cancer

  2011cited by this paper
• Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials.

  2011cited by this paper
• The Multifaceted Roles of USP7: New Therapeutic Opportunities

  2011influential reference
• MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines

  2011cited by this paper
• Analysis of the rpn11-m1 proteasomal mutant reveals connection between cell cycle and mitochondrial biogenesis.

  2011cited by this paper

• Neddylation: from regulatory mechanisms to clinical implications in cancer.

  2025cites this paper
• Role of TRIM24 in the regulation of proteasome-autophagy crosstalk in bortezomib-resistant mantle cell lymphoma

  2025cites this paper
• Deciphering potential molecular mechanisms in clear cell renal cell carcinoma based on the ubiquitin‐conjugating enzyme E2 related genes: Identifying UBE2C correlates to infiltration of regulatory T cells

  2024cites this paper
• Cannabidiol modulates hippocampal genes involved in mitochondrial function, ribosome biogenesis, synapse organization, and chromatin modifications

  2024cites this paper
• Cannabidiol administration reduces the expression of genes involved in mitochondrial electron transport chain and ribosome biogenesis in mice CA1 neurons

  2023cites this paper
• The interplay between lipid and Aβ amyloid homeostasis in Alzheimer's Disease: risk factors and therapeutic opportunities.

  2021cites this paper
• Identification of small molecules disrupting the ubiquitin proteasome system in malaria Running tittle: Inhibition of P. falciparum Ubiquitin Proteasome System

  2021cites this paper
• Approaches to Investigating the Protein Interactome of PTEN.

  2020cites this paper
• Effect of Metabolite Extract of Streptomyces hygroscopicus subsp. hygroscopicus on Plasmodium falciparum 3D7 in Vitro

  2019cites this paper
• Identification of small molecules disrupting the ubiquitin proteasome system in malaria.

  2019cites this paper
• An oral second-generation proteasome inhibitor oprozomib significantly inhibits lung cancer in a p53 independent manner in vitro.

  2019cites this paper
• Small Molecule Inhibitors Targeting New Targets of Protein-Protein Interactions

  2018cites this paper
• XIAP upregulates expression of HIF target genes by targeting HIF1α for Lys63-linked polyubiquitination

  2017cites this paper
• The double faced role of copper in Aβ homeostasis: A survey on the interrelationship between metal dyshomeostasis, UPS functioning and autophagy in neurodegeneration

  2017cites this paper
• Analysis of defective protein ubiquitylation associated to adriamycin resistant cells

  2017cites this paper
• Efficient monitoring of protein ubiquitylation levels using TUBEs‐based microarrays

  2016cites this paper
• New insights into host-parasite ubiquitin proteome dynamics in P. falciparum infected red blood cells using a TUBEs-MS approach.

  2016cites this paper
• Isolation of the Ubiquitin-Proteome from Tumor Cell Lines and Primary Cells Using TUBEs.

  2016cites this paper
• TUBEs-Mass Spectrometry for Identification and Analysis of the Ubiquitin-Proteome.

  2016cites this paper
• NEDDylation promotes endothelial dysfunction: a role for HDAC2.

  2015cites this paper
• The amazing ubiquitin-proteasome system: structural components and implication in aging.

  2015cites this paper
• Development of two novel high-throughput assays to quantify ubiquitylated proteins in cell lysates: application to screening of new anti-malarials

  2015cites this paper
• Systemic Proteasome Inhibition Induces Sustained Post-stroke Neurological Recovery and Neuroprotection via Mechanisms Involving Reversal of Peripheral Immunosuppression and Preservation of Blood–Brain–Barrier Integrity

  2015cites this paper
• Analysis of PTEN ubiquitylation and SUMOylation using molecular traps.

  2015cites this paper
• Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma

  2014cites this paper
• Uncovering ubiquitylation pathways in liver metabolism by a proteomic approach

  2014cites this paper
• Bases moleculars de l’activitat antitumoral de la lenalidomida en el limfoma de cèl•lules del mantell

  2014cites this paper
• The Ubiquitin-Proteasome System (UPS) as a Cancer Drug Target: Emerging Mechanisms and Therapeutics

  2014influential citation
• Proteasome inhibitors and knockdown of SMG1 cause accumulation of Upf1 and Upf2 in human cells.

  2014cites this paper
• The ubiquitin proteasome system as a source of drug targets for cancer therapy.

  2013cites this paper